Back to results
US 6,730,791 B2Granted
Antihistaminic piperidine derivatives and intermediates for the preparation thereof
AssigneeAventis Pharmaceuticals Inc.
InventorTimothy A. Ayers
Life of this patent
Estimating the term…
Abstract
This invention relates to novel compounds of the following formula and a process for the preparation thereof. wherein X is Cl, Br or I.
Claims12
A process for preparing a compound of the formula
- wherein X is Cl, Br, or I;
- comprising the steps of:
- (a) reacting a compound of the formula
- with a 4-halo-substituted butyrylhalide under Friedel-Crafts conditions to provide a mixture of para- and meta-substituted (4-halo-1-oxobutyl)-N-methoxy-N-methyl-benzeneacetamide of the formula
- wherein
- X is Cl, Br, or I;
- (b) selectively crystallizing and isolating substantially pure [4-(4-halo-1-oxobutyl)]-N-methoxy-N-methyl-benzeneacetamide of the formula
- wherein
- X is Cl, Br, or I;
- (c) hydrolyzing the substantially pure [4-(4-halo-1-oxobutyl)]-N-methoxy-N-methyl-benzeneacetamide to provide a (cyclopropylcarbonyl)benzeneacetic acid of the formula
- (d) esterifying the (cyclopropylcarbonyl)benzeneacetic acid to provide a (cyclopropylcarbonyl)benzeneacetic acid ester of the formula
- wherein
- R1 is C1-C6alkyl wherein the C1-C6alkyl moiety is straight or branched;
- (e) acylating the (cyclopropylcarbonyl)benzeneacetic acid ester to provide a [4-(cyclopropylcarbonyl)phenyl]propanedioic acid diester of the formula
- wherein
- R1 is H;
- R2 and R3 are each independently C1-C6alkyl wherein the C1-C6alkyl moiety is straight or branched;
- (f) optionally alkylating the [4-(cyclopropylcarbonyl)phenyl]propanedioic acid diester to provide a [4-(cyclopropylcarbonyl)phenyl]propanedioic acid diester of the formula
- wherein
- R1 is C1-C6alkyl wherein the C1-C6alkyl moiety is straight or branched and R2 and R3 each independently C1-C6alkyl wherein the C1-C6alkyl moiety is straight or branched;
- (g) reacting the [4-(cyclopropylcarbonyl)phenyl]propanedioic acid diester of the formula
- wherein
- R1 is H or C1-C6alkyl wherein the C1-C6alkyl moiety is straight or branched
- R2 and R3 are each independently C1-C6alkyl wherein the C1-C6alkyl moiety is straight or branched,
- with a suitable hydrogen halide to produce a [4-(4-halo-1-oxo-butyl)phenyl]propanedioic acid diester of formula
- wherein
- R1 is H or C1-C6alkyl wherein the C1-C6alkyl moiety is straight or branched;
- R2 and R3 are each independently C1-C6alkyl wherein the C1-C6alkyl moiety is straight or branched;
- X is Cl, Br or I;
- (h) reacting the [4-(4-halo-1-oxo-butyl)phenyl]propanedioic acid diester with a compound of formula
- to produce a [4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-oxobutyl]phenyl]propanedioic acid diester compound of formula
- wherein
- R1 is H or C1-C6alkyl wherein the C1-C6alkyl moiety is straight or branched;
- R2 and R3 are each independently C1-C6alkyl wherein the C1-C8alkyl moiety is straight or branched;
- or
- stereoisomers or pharmaceutically acceptable acid addition salt thereof;
- (i) reacting the [4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-oxobutyl]phenyl]propanedioic acid diester compound with a suitable selective reducing agent to give a 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α-(hydroxymethyl)-benzeneacetic acid ester compound of formula
- wherein
- R1 is H or C1-C6alkyl wherein the C1-C6alkyl moiety is straight or branched;
- R2 is —COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched;
- or
- stereoisomers or pharmaceutically acceptable acid addition salt thereof;
- and
- (j) optionally hydrolyzing the 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α-(hydroxymethyl)-benzeneacetic acid ester compound to produce a compound of formula
- wherein
- R1 is H or C1-C6alkyl wherein the C1-C6alkyl moiety is straight or branched
- R2 is —COOH;
- or
- stereoisomers or pharmaceutically acceptable acid addition salt thereof;
- with the proviso that each of the keto groups present in the compounds described in steps c-h are optionally protected or unprotected.
47 more elements
A process for preparing a compound of the formula
- wherein X is Cl, Br, or I;
- comprising the steps of:
- (b) reacting a compound of the formula
- with a 4-halo-substituted butyrylhalide under Friedel-Crafts conditions to provide a mixture of para- and meta-substituted (4-halo-1-oxobutyl)-N-methoxy-N-methyl-benzeneacetamide of the formula
- wherein
- X is Cl, Br, or I;
- (b) selectively crystallizing and isolating substantially pure [4-(4-halo-1-oxobutyl)]-N-methoxy-N-methyl-benzeneacetamide of the formula
- wherein
- X is Cl, Br, or I
- (c) hydrolyzing the substantially pure [4-(4-halo-1-oxobutyl)]-N-methoxy-N-methyl-benzeneacetamide to provide a (cyclopropylcarbonyl)benzeneacetic acid of the formula
- (d) esterifying the 4-(cyclopropylcarbonyl)benzene acetic acid to provide a corresponding 4-(cyclopropylcarbonyl)benzeneacetic acid ester of the formula
- wherein
- R1 is C1-C6alkyl wherein the C1-C6alkyl moiety is straight or branched;
- (e) alkylating the 4-(cyclopropylcarbonyl)benzeneacetic acid ester with a suitable alkylating agent to provide a corresponding alkylated [4-(cyclopropylcarbonyl)phenyl]benzeneacetic acid ester
- wherein
- R1 is as previously defined herein and R2 and R3 are each independently C1-C6alkyl wherein the C1-C6alkyl moiety is straight or branched;
- (f) ring-opening the alkylated [4-(cyclopropylcarbonyl)phenyl]benzene acetic acid ester to provide a corresponding [4-(4-halo-1-oxo-butyl)phenyl]benzene acetic acid ester of the formula
- wherein
- R1, R2 and R3 are as previously defined herein and X is Cl, Br or I;
- (g) reacting the alkylated [4-(4-halo-1-oxo-butyl)phenyl]benzeneacetic acid ester with a compound of the formula
- to produce a [4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-oxobutyl]phenyl]benzeneacetic acid ester of the formula
- wherein
- R1, R2 and R3 are as previously defined herein;
- or
- stereoisomers or pharmaceutically acceptable acid addition salt thereof;
- h) reacting the [4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-oxobutyl]phenyl]benzeneacetic acid ester with a suitable reducing agent to produce a 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]benzeneacetic acid ester of the formula
- wherein
- R1, R2 and R3 are as previously defined herein;
- or
- stereoisomers or pharmaceutically acceptable acid addition salt thereof;
- i) optionally hydrolyzing the 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]benzeneacetic acid ester to produce a compound of the formula
- wherein
- R2 and R3 are as previously defined herein;
- or
- stereoisomers or pharmaceutically acceptable acid addition salt thereof;
- with the proviso that each of the keto groups present in the compounds described in steps c-g are optionally protected or unprotected.
33 more elements
In a process for the synthesis of a compound of the formula
- wherein
- R1 is H or C1-C6alkyl wherein the C1-C6alkyl moiety is straight or branched;
- R2 is —COOH or —COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched;
- or
- stereoisomers or pharmaceutically acceptable acid addition salt thereof, using as an intermediate a compound of the formula
- wherein
- X is Cl, Br, or I;
- the improvement wherein said intermediate compound was prepared according to the process comprising
- (a) reacting a compound of the formula
- with 4-halo-substituted butyrylhalide under Friedel-Crafts conditions to provide a mixture of para- and meta-substituted (4-halo-1-oxobutyl)-N-methoxy-N-methyl-benzeneacetamide of the formula
- wherein
- X is Cl, Br, or I and
- (b) selectively crystallizing and isolating substantially pure [4-(4-halo-1-oxobutyl)]-N-methoxy-N-methyl-benzeneacetamide of the formula
- wherein
- X is Cl, Br, or I.
12 more elements
In a process for the synthesis of a compound of the formula
- wherein
- R1 is H or C1-C6alkyl wherein the C1-C6alkyl moiety is straight or branched, and R2 and R3 are each independently C3-C6alkyl wherein the C3-C6alkyl moiety is straight or branched;
- or
- stereoisomers or pharmaceutically acceptable acid addition salt thereof;
- using as an intermediate a compound of the formula
- wherein
- X is Cl, Br, or I;
- the improvement wherein said intermediate compound was prepared according to the process comprising
- (a) reacting a compound of the formula
- with 4-halo-substituted butyrylhalide under Friedel-Crafts conditions to provide a mixture of para- and meta-substituted (4-halo-1-oxobutyl)-N-methoxy-N-methyl-benzeneacetamide of the formula
- wherein
- X is Cl, Br, or I;
- and
- (b) selectively crystallizing and isolating substantially pure [4-(4-halo-1-oxobutyl)]-N-methoxy-N-methyl-benzeneacetamide of the formula
11 more elements
Dependencies are inferred from the claim text.